Wanyong Lian - SINOPHARM Insider

SINOPHARM -- Hong Kong Stock  

HKD 30.05  0.2  0.66%

Supervisor

Mr. Lian Wanyong is NonExecutive Director of Sinopharm Group Co., Ltd. He joined the Company on 22 December 2008 as a nonexecutive Director and had been a Supervisor since 7 January 2011. He has over 16 years of working experience, all of which is management experience. Mr. Lian obtained a bachelors degree in medicine, majoring in clinical medicine, from Hunan University of Medicine in July 1993, a masters degree in medicine, majoring in pharmacology, from Zhongshan Medicine University in July 1996 and a masters degree in business administration from the University of Miami in May 2002. Mr. Lian was previously the manager of the operation and audit department of China National Group Corporationration of Traditional Herbal Medicine and a deputy head of the financial assets management department of CNPGC from January 2004 to June 2005 and from June 2005 to February 2008, respectively. Mr. Lian was the head of the investment management department of CNPGC since February 2008.
Age: 45  Executive Since 2016      
86 21 2305 2666  http://www.sinopharmholding.com/En

Management Efficiency

The company has return on total asset (ROA) of 4.16 % which means that it generated profit of $4.16 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 15.8 % meaning that it generated $15.8 on every $100 dollars invested by stockholders.
The company has accumulated 6.57 B in total debt with debt to equity ratio (D/E) of 90.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SINOPHARM has Current Ratio of 1.23 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Xiu SongWEIGAO GROUP
N/A
Wenyun YangHealth and Happiness Internatio
2010
Li ZhaoHealth and Happiness Internatio
2014
Jia ChenTONG REN TANG
N/A
De ZhouWEIGAO GROUP
2009
Miu WongWEIGAO GROUP
N/A
Wenhui CaoHealth and Happiness Internatio
N/A
Fangming HuHealth and Happiness Internatio
2014
Yidong WangHealth and Happiness Internatio
2016
Hong LiBAIYUNSHAN PH
2017
Guangfeng SuBAIYUNSHAN PH
2005
De YangTONG REN TANG
N/A
Gui GuoTONG REN TANG
N/A
Tak WongHealth and Happiness Internatio
2010
Cun LiuTONG REN TANG
N/A
Yuk ChanWEIGAO GROUP
N/A
Jiahua PengHealth and Happiness Internatio
2015
Jianhui PangBAIYUNSHAN PH
2008
Da LiTONG REN TANG
2014

Entity Summary

Sinopharm Group Co.Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare solutions in the People?s Republic of China. SINOPHARM (1099) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Sinopharm Group Co., Ltd.Shanghai, and employs 55,869 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SINOPHARM to your portfolio

Top Management

SINOPHARM Leadership Team
Jindong Deng, Director
Hailiang Liu, Director
Tze Yu, Director
Fang Yao, Executive
Guangpu Li, President
Yong Liu, VP
Qunbin Wang, Director
Yuhua Li, Director
Bin Zhou, Director
Junyu Guo, President
Lulin She, Chairman
Ping Ma, Director
Wanyong Lian, Executive
Qiyu Chen, Director
Ling Li, Director
Deyong Wen, Director
Zhiming Li, President
Zheng Liu, Director
Fumin Zhuo, Director
Xiuchang Jiang, CFO
Wee Tan, Director
Jun Lu, President
Yulin Wei, President
Chang Lyu, Director
Yijian Wu, Director
Wanjun Ma, President
Guangfu Li, President
Dongjiu Li, Director
Shuangjun Xu, President
Wei Liu, Executive, Ph.D
Zhongxi Cai, President, Ph.D
Qi Chen, Chairman

Stock Performance

SINOPHARM Performance Indicators